Ebola Deaths in Eastern Congo Rise to 131 as Outbreak Spreads, Alarming WHO
Latest Developments in the Eastern Congo Ebola Outbreak
By Erikas Mwisi
Rising Death Toll and Spread of the Virus
BUNIA, Democratic Republic of Congo, May 19 (Reuters) - Twenty-six more suspected Ebola deaths were recorded in 24 hours in eastern Democratic Republic of Congo, authorities said on Tuesday, and the head of the World Health Organization expressed deep concern about the outbreak's spread.
The new deaths bring to 131 the fatalities associated with the outbreak in eastern DRC. There have been 516 suspected cases and 33 confirmed cases in DRC, according to a daily bulletin published by health authorities, and two confirmed cases in neighbouring Uganda.
WHO's Response and Public Health Emergency Declaration
WHO Director-General Tedros Adhanom Ghebreyesus declared the outbreak of the rare Bundibugyo strain of the virus a public health emergency of international concern on Saturday, the first time a WHO chief has done so before convening an emergency committee.
Challenges in Containment
The outbreak has alarmed experts because it was able to spread for weeks undetected across a densely populated area ravaged by widespread armed violence. A 2018-2020 outbreak in eastern DRC was the second deadliest on record, killing nearly 2,300 people.
New Cases in Butembo and Border Restrictions
Butembo, a city of hundreds of thousands of people in North Kivu province, recorded its first two confirmed cases on Monday, Jean-Jacques Muyembe, director of Congo's National Institute for Biomedical Research (INRB), told Reuters.
Ugandan authorities have started restricting movement across the Ishasha-Kyeshero border crossing to limit further spillover of the virus, Ambrose Amanyire Mwesigye, a local government official, told Reuters. He said the border was not closed but did not explain who might be allowed to cross.
Further south, Congolese people trying to cross into Rwanda from the cities of Goma and Bukavu were being stopped at the border, Reuters reporters said. Rwandan officials could not immediately be reached for comment.
The WHO had on Saturday urged countries not to close their borders, saying this could lead to informal border crossings that are not monitored.
International Response and Evacuations
Americans to Be Evacuated to Germany
AMERICANS TO BE EVACUATED TO GERMANY
Ebola, which spreads through direct contact with bodily fluids from infected people or animals, has an average fatality rate of around 50%, according to the WHO.
"I'm deeply concerned about the scale and speed of the epidemic," Tedros told members of the World Health Assembly in Geneva on Tuesday, citing the number of cases being reported in urban areas and among healthcare workers.
Six tons of supplies, including personal protective equipment, were set to arrive in DRC on Tuesday, in addition to the 12 tons that had already been delivered, said Anne Ancia, the WHO's representative in DRC.
One American tested positive for Ebola as part of their work in Congo, the U.S. Centers for Disease Control and Prevention said on Monday.
The individual, identified as Dr Peter Stafford by his Christian mission organisation, and six other Americans who were exposed to the virus were being moved to Germany for care and monitoring, the CDC said.
The CDC also said it was suspending entry of travellers into the U.S. who had been in the DRC, Uganda or South Sudan during the past 21 days, with certain exceptions, for 30 days to reduce the risk of Ebola spread.
Efforts to Develop Treatments and Vaccines
Current Limitations and Ongoing Research
EXPERTS TRY TO DEVELOP TREATMENTS AND VACCINES
Unlike with the more common Zaire strain of Ebola, there is no approved virus-specific therapeutics or vaccine for the Bundibugyo strain.
The U.S., which said it had mobilised an initial $13 million to respond to the outbreak, is working to develop a monoclonal antibody therapy as a potential treatment, the CDC said on Monday.
Potential Vaccine Candidates
A panel of experts led by the WHO will also meet on Tuesday to discuss if there are any vaccine options to help tackle the outbreak. The WHO's Ancia said Merck & Co's Ervebo was one candidate but that it would take two months to be available.
International Cooperation and Funding Challenges
The U.S. officially left the WHO in January in a move President Donald Trump said was motivated by the organisation's poor management of the COVID-19 pandemic.
Ancia said the WHO had been working "very well" with the U.S. government on the Ebola outbreak but reductions in health funding had had a "tremendous impact" on the organisation's ability to counter the disease. Under Trump the U.S. has slashed global health funding. Other major donors have also made cuts.
(Additional reporting by Jennifer Rigby in London, Olivia Le Poidevin and Emma Farge in Geneva and Elias Biryabarema in Kampala; Writing by Aaron Ross; Editing by Timothy Heritage)
